Loading...
Indian Pharmaceutical Exporter · #6 for Kit · $7.8M export value · DGFT Verified
Sandoz Private Limited is the #6 Indian exporter of Kit with $7.8M in export value and 175 verified shipments. Sandoz Private Limited holds a 1.8% market share in Kit exports across 28 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.
| 12 |
| 5.6% |
| PHILIPPINES | $175.3K | 7 | 4.1% |
| BANGLADESH | $166.5K | 11 | 3.9% |
| SOMAALIA | $156.7K | 8 | 3.7% |
| TANZANIA | $145.3K | 5 | 3.4% |
| MYANMAR | $144.5K | 6 | 3.4% |
Sandoz Private Limited exports Kit to 29 countries. The largest destination is BRAZIL accounting for 16.0% of Sandoz Private Limited's Kit shipments, followed by SWITZERLAND (13.0%) and INDONESIA (12.9%). These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| WORLD HEALTH ORGANIZATION | SWITZERLAND | $1.7M | 75 |
| MINISTERIO DA SAUDE-CGRL | BRAZIL | $679.7K | 16 |
| WORLD HEALTH ORGANISATION | PHILIPPINES | $403.3K | 21 |
| WHO COUNTRY OFFICE, INDONESIA | INDONESIA | $219.6K | 9 |
| WHO COUNTRY OFFICE,INDONESIA | INDONESIA | $183.3K | 4 |
| ORGANIZACAO MUNDIAL DE SAUDE | MOZAMBIQUE | $182.1K | 10 |
| WORLD HEALTH REPRESENTATIVE | BANGLADESH | $141.3K | 9 |
| ORGANISATION MONDIALE DE LA SANTE | COTE D IVOIRE | $133.3K | 5 |
| WORLD HEALTH ORGANIZATION, | SOMAALIA | $104.9K | 6 |
| WHO COUNTRY OFFICE INDONESIA | INDONESIA | $93.6K | 4 |
Sandoz Private Limited supplies Kit to 19 buyers globally. The largest buyer is WORLD HEALTH ORGANIZATION (SWITZERLAND), followed by MINISTERIO DA SAUDE-CGRL (BRAZIL) and WORLD HEALTH ORGANISATION (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $57.8M worth of Kit through 15,000 shipments from 1048 suppliers to 191 countries, serving 3,293 buyers globally. Sandoz Private Limited contributes $7.8M to this total, accounting for 1.8% of India's Kit exports. Sandoz Private Limited ships Kit to 29 countries through 19 buyers.
Sandoz Private Limited's average Kit shipment value is $44.6K per consignment, based on 175 shipments totaling $7.8M. The largest destination is BRAZIL (16.0% of Sandoz Private Limited's Kit exports).
Sandoz Private Limited ranks #6 among 1048 Indian Kit exporters with a 1.8% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($7.8M), MERIL DIAGNOSTICS PRIVATE LIMITED ($5.6M), MICRO LABS LIMITED ($5.5M). Sandoz Private Limited processed 175 shipments to 28 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Material No. - 44032565 MB ADULT 360KIT | $1.2M | 30 |
| MATERIAL NO. - 44032565 MB ADULT 360KITINT (MFG LICENCE NO.: KD-390) | $631.9K | 16 |
| Material No 44103144 MB ADULT 360KITV1 INT MFG LICENCE NO KD 390 | $300.0K | 6 |
| Material No. - 44032565 MB ADULT 360KITINT (MFG LICENCE NO.: KD-390) | $277.0K | 6 |
| Material No 44032565 MB ADULT 360KITINT MFG LICENCE NO KD 390 | $185.1K | 6 |
| Material No. - 44032596 MB CHILD 288KIT | $178.3K | 26 |
| MATERIAL NO.44032565 MB ADULT 360KIT INT MFG LICENCE NO:KD390 | $150.0K | 3 |
| MATERIAL NO. - 44032565 MB ADULT 360KIT INT (MFG LICENCE NO.: KD-390)PCS | $126.4K | 4 |
| Material No. - 44032563 PB ADULT 180KIT | $76.7K | 17 |
| Material No. - 44103144 MB ADULT 360KITV1 INT (MFG LICENCE NO.: KD-390) | $64.6K | 2 |
Sandoz Private Limited exports 54 distinct Kit formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Material No. - 44032565 MB ADULT 360KIT with 30 shipments worth $1.2M.
What Sandoz Private Limited must comply with to export Kit to its top destination countries
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | SANDOZ PRIVATE LIMITED ★ | $7.8M | 175 | 28 | $44.6K |
| 8 | MERIL DIAGNOSTICS PRIVATE LIMITED | $5.6M | 645 | 64 | $8.7K |
| 9 | MICRO LABS LIMITED | $5.5M | 193 | 22 | $28.5K |
Sandoz Private Limited ranks #6 among 1048 Indian Kit exporters. Average shipment value of $44.6K compared to the market average of $55.1K. The closest competitors by value are MERIL DIAGNOSTICS PRIVATE LIMITED and MICRO LABS LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,763 | 18.4% |
| SAHAR AIR | 2,534 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,051 | 7.0% |
| DELHI AIR | 983 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 901 | 6.0% |
| Bombay Air | 541 | 3.6% |
| JNPT/ NHAVA SHEVA SEA | 433 | 2.9% |
| CHENNAI AIR CARGO ACC (INMAA4) | 405 | 2.7% |
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.
Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.
The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.
Sandoz Private Limited exports 25 products worth $159.4M. Beyond Kit, top products include Tacrolimus, Apixaban, Citalopram, Escitalopram, Gabapentin. View the complete Sandoz Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Kit — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 191+ countries, 3,293+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sandoz Private Limited's Kit exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sandoz Private Limited
Full Company Profile →
25 products · $159.4M total trade · 15 categories
Access shipment-level records, pricing trends, and buyer contacts for Sandoz Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Kit. For current shipment-level data, contact TransData Nexus.